Skip to main content

Advertisement

SpringerLink
Log in

Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. J.P. Bilezikian, M.L. Brandi, M. Rubin, S.J. Silverberg, Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J. Intern. Med. 257(1), 6–17 (2005). doi:10.1111/j.1365-2796.2004.01422.x

    Article  CAS  PubMed  Google Scholar 

  2. S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341(17), 1249–1255 (1999). doi:10.1056/NEJM199910213411701

    Article  CAS  PubMed  Google Scholar 

  3. M.R. Rubin, J.P. Bilezikian, D.J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, S.J. Silverberg, The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab. 93(9), 3462–3470 (2008). doi:10.1210/jc.2007-1215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. R. Eastell, A. Arnold, M.L. Brandi, E.M. Brown, P. D’Amour, D.A. Hanley, D.S. Rao, M.R. Rubin, D. Goltzman, S.J. Silverberg, S.J. Marx, M. Peacock, L. Mosekilde, R. Bouillon, E.M. Lewiecki, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94(2), 340–350 (2009). doi:10.1210/jc.2008-1758

    Article  CAS  PubMed  Google Scholar 

  5. J.P. Bilezikian, A.A. Khan, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab. 94(2), 335–339 (2009). doi:10.1210/jc.2008-1763

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. E.F. Nemeth, W.H. Heaton, M. Miller, J. Fox, M.F. Balandrin, B.C. Van Wagenen, M. Colloton, W. Karbon, J. Scherrer, E. Shatzen, G. Rishton, S. Scully, M. Qi, R. Harris, D. Lacey, D. Martin, Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J. Pharmacol. Exp. Ther. 308(2), 627–635 (2004). doi:10.1124/jpet.103.057273

    Article  CAS  PubMed  Google Scholar 

  7. C. Valle, M. Rodriguez, R. Santamaria, Y. Almaden, M.E. Rodriguez, S. Canadillas, A. Martin-Malo, P. Aljama, Cinacalcet reduces the set point of the PTH-calcium curve. J. Am. Soc. Nephrol. 19(12), 2430–2436 (2008). doi:10.1681/ASN.2007121320

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. N. Verheyen, S. Pilz, K. Eller, K. Kienreich, A. Fahrleitner-Pammer, B. Pieske, E. Ritz, A. Tomaschitz, Cinacalcet hydrochloride for the treatment of hyperparathyroidism. Expert Opin. Pharmacother. 14(6), 793–806 (2013). doi:10.1517/14656566.2013.777041

    Article  CAS  PubMed  Google Scholar 

  9. M.H. Gault, L.L. Longerich, J.D. Harnett, C. Wesolowski, Predicting glomerular function from adjusted serum creatinine. Nephron 62(3), 249–256 (1992)

    Article  CAS  PubMed  Google Scholar 

  10. H.K. Genant, C.Y. Wu, C. van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8(9), 1137–1148 (1993). doi:10.1002/jbmr.5650080915

    Article  CAS  PubMed  Google Scholar 

  11. A.A. Khan, J.P. Bilezikian, A.W. Kung, M.M. Ahmed, S.J. Dubois, A.Y. Ho, D. Schussheim, M.R. Rubin, A.M. Shaikh, S.J. Silverberg, T.I. Standish, Z. Syed, Z.A. Syed, Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89(7), 3319–3325 (2004). doi:10.1210/jc.2003-03090889/7/3319

    Article  CAS  PubMed  Google Scholar 

  12. A. Khan, A. Grey, D. Shoback, Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94(2), 373–381 (2009). doi:10.1210/jc.2008-1762

    Article  CAS  PubMed  Google Scholar 

  13. M. Peacock, J.P. Bilezikian, M.A. Bolognese, M. Borofsky, S. Scumpia, L.R. Sterling, S. Cheng, D. Shoback, Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J. Clin. Endocrinol. Metab. 96(1), E9–E18 (2011). doi:10.1210/jc.2010-1221

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. M.L. Brandi, R.F. Gagel, A. Angeli, J.P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R.G. Gheri, A. Libroia, C.J. Lips, G. Lombardi, M. Mannelli, F. Pacini, B.A. Ponder, F. Raue, B. Skogseid, G. Tamburrano, R.V. Thakker, N.W. Thompson, P. Tomassetti, F. Tonelli, S.A. Wells Jr, S.J. Marx, Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86(12), 5658–5671 (2001). doi:10.1210/jcem.86.12.8070

    Article  CAS  PubMed  Google Scholar 

  15. N. Yu, G.P. Leese, D. Smith, P.T. Donnan, The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 104(6), 513–521 (2011). doi:10.1093/qjmed/hcq261

    Article  CAS  PubMed  Google Scholar 

  16. S. Corbetta, G. Mantovani, A. Lania, S. Borgato, L. Vicentini, E. Beretta, G. Faglia, A.M. Di Blasio, A. Spada, Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol 52(3), 339–348 (2000)

    Article  CAS  Google Scholar 

  17. J. Gogusev, P. Duchambon, B. Hory, M. Giovannini, Y. Goureau, E. Sarfati, T.B. Drueke, Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 51(1), 328–336 (1997)

    Article  CAS  PubMed  Google Scholar 

  18. C.A. Frolik, E.C. Black, R.L. Cain, J.H. Satterwhite, P.L. Brown-Augsburger, M. Sato, J.M. Hock, Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 33(3), 372–379 (2003)

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. Nothing to declare about financial disclosure.

Author information

Authors and Affiliations

  1. Department of Clinical Medicine and Surgery, Federico II University of Naples, Via S. Pansini 5, 80131, Naples, Italy

    Vincenzo Marotta, Carolina Di Somma, Manila Rubino, Concetta Sciammarella, Michela Del Prete, Francesca Marciello, Valeria Ramundo, Pasqualina Buonomano, Roberta Modica, Annamaria Colao & Antongiulio Faggiano

  2. National Cancer Institute, “Fondazione G. Pascale”, Naples, Italy

    Luisa Circelli & Antongiulio Faggiano

  3. Department of Medicine and Surgery, University of Salerno, Baronissi, Italy

    Mario Vitale

Authors
  1. Vincenzo Marotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolina Di Somma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manila Rubino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Concetta Sciammarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michela Del Prete
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesca Marciello
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Valeria Ramundo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luisa Circelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pasqualina Buonomano
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Roberta Modica
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mario Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Antongiulio Faggiano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincenzo Marotta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marotta, V., Di Somma, C., Rubino, M. et al. Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. Endocrine 49, 274–278 (2015). https://doi.org/10.1007/s12020-014-0381-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0381-0

Keywords

Search

Navigation